We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunoassay Module Integrated on Platform with Clinical Chemistry

By LabMedica International staff writers
Posted on 29 Jul 2010
A new immunoassay module can be integrated with clinical chemistry testing on a single platform.

The latest addition to the cobas 8000 platform suitable for large volume labs is the cobas e 602 module. More...
It runs more than 80 different immunoassays--from high medical value tests for cardiac and infectious diseases to bone markers, rheumatoid arthritis, tumor markers, and tests for maternal care--with a throughput of 170 tests per hour.

The cobas 8000 modular analyzer series offer 19 different configurations and has many new design and process elements such as the module sample buffer in each module, independent transport and return lines, switch gates, and many more features optimizing sample routing to achieve maximum efficiency and productivity.

In addition, the new cobas e 602 module uses the same operator interface, detection technologies and reagents as other cobas instruments, enabling standardization of results between different analyzers.

The cobas 8000 modular analyzer series is the newest member of Roche's (Basel, Switzerland) cobas modular platform family. It is designed to meet the needs of high volume laboratories with about 3 to 15 million tests per year to deliver high quality results quickly and efficiently from a single patient sample. The cobas 8000 compliments the cobas 6000 modular analyzer for medium-sized laboratories and the cobas 4000 systems for small workloads.

Roche offers seven additional configurations to the cobas 8000 modular analyzer series by combining the previously launched clinical chemistry modules with the immunoassay module for serum work area testing.

The new cobas e 602-immunoassay module is available in Europe as well as in all countries recognizing CE marking in the Latin America and Asia-Pacific regions.

With the launch of the high volume immunochemistry module, customers can consolidate clinical chemistry and immunochemistry testing in different ways into one single configuration. The cobas 8000 modular analyzer series offers 19 different configurations and includes many design and process elements such as the Module Sample Buffer in each module, independent transport and return lines, switch gates, and other features optimizing sample routing to achieve maximum efficiency and productivity.

Roche is a leader in research-focused healthcare with combined strengths in diagnostics and pharmaceutics. The company is an important provider of in vitro diagnostics (IVD), tissue-based cancer diagnostics, and diabetes management.

Related Links:

Roche's



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.